Christopher G. Wood

27.8k total citations · 4 hit papers
409 papers, 16.0k citations indexed

About

Christopher G. Wood is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Christopher G. Wood has authored 409 papers receiving a total of 16.0k indexed citations (citations by other indexed papers that have themselves been cited), including 282 papers in Pulmonary and Respiratory Medicine, 191 papers in Molecular Biology and 162 papers in Surgery. Recurrent topics in Christopher G. Wood's work include Renal cell carcinoma treatment (253 papers), Renal and related cancers (149 papers) and Bladder and Urothelial Cancer Treatments (127 papers). Christopher G. Wood is often cited by papers focused on Renal cell carcinoma treatment (253 papers), Renal and related cancers (149 papers) and Bladder and Urothelial Cancer Treatments (127 papers). Christopher G. Wood collaborates with scholars based in United States, France and Canada. Christopher G. Wood's co-authors include Surena F. Matin, Vitaly Margulis, Pheroze Tamboli, Nizar M. Tannir, José A. Karam, Eric Jonasch, David A. Swanson, Shahrokh F. Shariat, Ashish M. Kamat and Richard Zigeuner and has published in prestigious journals such as The Lancet, Angewandte Chemie International Edition and Nature Communications.

In The Last Decade

Christopher G. Wood

396 papers receiving 15.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Epidemiology of Renal Cell Carcinoma

2018 1.0k citations Karim Bensalah, Christopher G. Wood et al. profile →
Outcomes of radical nephroureterectomy: A series from the Upper Tract Urothelial Carcinoma Collaboration

2009 780 citations Vitaly Margulis, Shahrokh F. Shariat et al. Cancer profile →
Prognostic Value of Histologic Subtypes in Renal Cell Carcinoma: A Multicenter Experience

2005 535 citations Nathalie Rioux‐Leclercq, Christopher G. Wood et al. Journal of Clinical Oncology profile →
Prognostic Factors in Upper Urinary Tract Urothelial Carcinomas: A Comprehensive Review of the Current Literature

2012 311 citations Vitaly Margulis, Surena F. Matin et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christopher G. Wood United States	64	9.2k	7.4k	6.0k	4.1k	3.3k	409	16.0k
Axel S. Merseburger Germany	50	9.6k 1.0×	5.9k 0.8×	4.1k 0.7×	2.6k 0.6×	2.5k 0.7×	421	14.3k
Steven C. Campbell United States	67	14.1k 1.5×	10.3k 1.4×	4.9k 0.8×	2.6k 0.6×	2.0k 0.6×	365	18.9k
Michael A.S. Jewett Canada	69	8.9k 1.0×	6.5k 0.9×	6.1k 1.0×	2.5k 0.6×	2.0k 0.6×	418	15.7k
Mitchell C. Benson United States	52	8.6k 0.9×	3.9k 0.5×	3.1k 0.5×	2.2k 0.5×	2.8k 0.8×	268	13.3k
Alexandre de la Taille France	68	10.8k 1.2×	5.2k 0.7×	3.7k 0.6×	2.6k 0.6×	1.9k 0.6×	471	15.7k
Brett Delahunt New Zealand	54	10.8k 1.2×	5.9k 0.8×	3.0k 0.5×	3.0k 0.7×	1.9k 0.6×	300	14.2k
Daniel W. Lin United States	53	7.1k 0.8×	7.7k 1.0×	2.3k 0.4×	7.1k 1.7×	2.0k 0.6×	273	16.9k
Karim Bensalah France	53	9.2k 1.0×	5.5k 0.7×	3.9k 0.7×	2.0k 0.5×	2.0k 0.6×	330	12.7k
Markus A. Kuczyk Germany	47	7.1k 0.8×	5.3k 0.7×	3.3k 0.5×	1.8k 0.4×	1.8k 0.5×	281	11.3k
Surena F. Matin United States	58	8.0k 0.9×	5.1k 0.7×	6.6k 1.1×	1.8k 0.4×	1.9k 0.6×	392	13.1k

Countries citing papers authored by Christopher G. Wood

Since Specialization

Citations

This map shows the geographic impact of Christopher G. Wood's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher G. Wood with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher G. Wood more than expected).

Fields of papers citing papers by Christopher G. Wood

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher G. Wood. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher G. Wood. The network helps show where Christopher G. Wood may publish in the future.

Co-authorship network of co-authors of Christopher G. Wood

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher G. Wood. A scholar is included among the top collaborators of Christopher G. Wood based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher G. Wood. Christopher G. Wood is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Figlin, Robert A., Nizar M. Tannir, Robert G. Uzzo, et al.. (2020). Results of the ADAPT Phase 3 Study of Rocapuldencel-T in Combination with Sunitinib as First-Line Therapy in Patients with Metastatic Renal Cell Carcinoma. Clinical Cancer Research. 26(10). 2327–2336. 53 indexed citations

Choueiri, Toni K., Michael B. Atkins, Ziad Bakouny, et al.. (2020). Summary From the First Kidney Cancer Research Summit, September 12–13, 2019: A Focus on Translational Research. JNCI Journal of the National Cancer Institute. 113(3). 234–243. 15 indexed citations

Zacharias, Niki M., Natalia Baran, Sriram S. Shanmugavelandy, et al.. (2019). Assessing Metabolic Intervention with a Glutaminase Inhibitor in Real-Time by Hyperpolarized Magnetic Resonance in Acute Myeloid Leukemia. Molecular Cancer Therapeutics. 18(11). 1937–1946. 22 indexed citations

Shu, Xiang, Mark P. Purdue, Yuanqing Ye, et al.. (2017). Potential Susceptibility Loci Identified for Renal Cell Carcinoma by Targeting Obesity-Related Genes. Cancer Epidemiology Biomarkers & Prevention. 26(9). 1436–1442. 3 indexed citations

Malouf, Gabriel G., Xiaoping Su, Jianping Zhang, et al.. (2016). DNA Methylation Signature Reveals Cell Ontogeny of Renal Cell Carcinomas. Clinical Cancer Research. 22(24). 6236–6246. 39 indexed citations

Vartolomei, Mihai Dorin, Romain Mathiéu, Vitaly Margulis, et al.. (2016). Promising role of preoperative neutrophil-to-lymphocyte ratio in patients treated with radical nephroureterectomy. World Journal of Urology. 35(1). 121–130. 34 indexed citations

Gu, Jian, Luis A. Herrera, Nizar M. Tannir, et al.. (2015). Genomic DNA Hypomethylation and Risk of Renal Cell Carcinoma: A Case–Control Study. Clinical Cancer Research. 22(8). 2074–2082. 22 indexed citations

Phan, Liem, Enrique Fuentes‐Mattei, Weixin Wu, et al.. (2015). Hepatocyte Growth Factor/cMET Pathway Activation Enhances Cancer Hallmarks in Adrenocortical Carcinoma. Cancer Research. 75(19). 4131–4142. 34 indexed citations

Haas, Naomi B., Judith Manola, Bonnie Ky, et al.. (2015). Effects of Adjuvant Sorafenib and Sunitinib on Cardiac Function in Renal Cell Carcinoma Patients without Overt Metastases: Results from ASSURE, ECOG 2805. Clinical Cancer Research. 21(18). 4048–4054. 46 indexed citations

10.

Adibi, Mehrad, Arun Z. Thomas, Leonardo D. Borregales, et al.. (2015). Surgical considerations for patients with metastatic renal cell carcinoma. Urologic Oncology Seminars and Original Investigations. 33(12). 528–537. 23 indexed citations

11.

Malouf, Gabriel G., Xiaoping Su, Hui Yao, et al.. (2014). Next-Generation Sequencing of Translocation Renal Cell Carcinoma Reveals Novel RNA Splicing Partners and Frequent Mutations of Chromatin-Remodeling Genes. Clinical Cancer Research. 20(15). 4129–4140. 97 indexed citations

12.

Su, Shih-Chi, Xiaoxiao Hu, Patrick A. Kenney, et al.. (2013). Autotaxin–Lysophosphatidic Acid Signaling Axis Mediates Tumorigenesis and Development of Acquired Resistance to Sunitinib in Renal Cell Carcinoma. Clinical Cancer Research. 19(23). 6461–6472. 42 indexed citations

13.

Malouf, Gabriel G., Federico A. Monzon, Jérôme Couturier, et al.. (2013). Genomic Heterogeneity of Translocation Renal Cell Carcinoma. Clinical Cancer Research. 19(17). 4673–4684. 61 indexed citations

14.

Culp, Stephen H., Nizar M. Tannir, E. Jason Abel, et al.. (2010). Can we better select patients with metastatic renal cell carcinoma for cytoreductive nephrectomy?. Cancer. 116(14). 3378–3388. 139 indexed citations

15.

Jonasch, Eric, Christopher G. Wood, Surena F. Matin, et al.. (2009). Phase II Presurgical Feasibility Study of Bevacizumab in Untreated Patients With Metastatic Renal Cell Carcinoma. Journal of Clinical Oncology. 27(25). 4076–4081. 136 indexed citations

16.

Oflazoglu, Ezogelin, Ivan J. Stone, Kristine A. Gordon, et al.. (2008). Potent Anticarcinoma Activity of the Humanized Anti-CD70 Antibody h1F6 Conjugated to the Tubulin Inhibitor Auristatin via an Uncleavable Linker. Clinical Cancer Research. 14(19). 6171–6180. 93 indexed citations

17.

Kikuchi, Eiji, Vitaly Margulis, Pierre I. Karakiewicz, et al.. (2008). Lymphovascular Invasion Predicts Clinical Outcomes in Patients With Node-Negative Upper Tract Urothelial Carcinoma. Journal of Clinical Oncology. 27(4). 612–618. 215 indexed citations

18.

Kim, Jean Hee, Eric Jonasch, Angela Alexander, et al.. (2008). Cytoplasmic Sequestration of p27 via AKT Phosphorylation in Renal Cell Carcinoma. Clinical Cancer Research. 15(1). 81–90. 51 indexed citations

19.

Itamochi, Hiroaki, Linda X.H. Yuan, Francisco J. Esteva, et al.. (2005). Bcl-2 Antisense Oligonucleotide Overcomes Resistance toE1AGene Therapy in a Low HER2-Expressing Ovarian Cancer Xenograft Model. Cancer Research. 65(18). 8406–8413. 18 indexed citations

20.

Roberts, David J., et al.. (2003). Tackling isolation and the expression of emotion in a virtual medium. ANZ Journal of Surgery. 86(10). 831–835. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact